Striatum: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
---|---|---|---|---|---|---|---|---|---|---|---|
NCBI access number | Gene symbol | Number of isoforms | Protein name | Expression ratio (KO vs. wt) | T test (p-value) | Mowse score | Sequence coverage (%) | Number of matched peptides | Molecular weight (Da) | Theoretical pI | Functional annotation (KEGG pathway) |
gi|6753428 | Ckmt1 | 1 | creatine kinase, mitochondrial 1, ubiquitous | 1.37 | 0.0002 | 235 | 12 | 5 | 46974 | 8.39 | Metabolic pathways; Arginine and proline metabolism |
gi|6755929 | Uchl1 | 7 | ubiquitin carboxy-terminal hydrolase L1 | 1.45 | 0.0008 | 67 | 47 | 9 | 24822 | 5.33 | Parkinson's disease |
gi|3766201 | Sucla2 | 4 | ATP-specific succinyl-CoA synthetase beta subunit | 1.42 | 0.001 | 299 | 21 | 6 | 46215 | 5.65 | Metabolic pathways; Citrate cycle (TCA cycle); Propanoate metabolism; |
gi|6678674 | Ldhb | 5 | lactate dehydrogenase 2, B chain | 1.37 | 0.0012 | 136 | 51 | 2 | 36549 | 5.7 | Metabolic pathways; Propanoate metabolism; Glycolysis/Gluconeogenesis; Pyruvate metabolism; |
gi|31980844 | Dhrs1 | 2 | dehydrogenase/reductase (SDR family) member 1 | 1.54 | 0.0016 | 395 | 21 | 7 | 33983 | 8.66 | Â |
gi|10946574 | Ckb | 5 | creatine kinase, brain | 1.42 | 0.0018 | 465 | 25 | 8 | 42686 | 5.4 | Metabolic pathways; Arginine and proline metabolism |
gi|112363107 | Nefm | 7 | Neurofilament triplet M protein | 0.43 | 0.0025 | 56 | 12 | 2 | 95984 | 4.76 | Amyotrophic lateral sclerosis (ALS) |
gi|6680117 | Gss | 3 | glutathione synthetase | 1.42 | 0.0035 | 436 | 16 | 8 | 52214 | 5.56 | Metabolic pathways; Glutathione metabolism; |
gi|15277976 | Ndrg2 | 3 | N-myc downstream regulated gene 2 | 1.4 | 0.0046 | 93 | 6 | 2 | 40763 | 5.23 | Â |
gi|809561 | Actg1 | 4 | gamma-actin | 1.32 | 0.0048 | 84 | 5 | 2 | 40992 | 5.56 | Regulation of actin cytoskeleton |
gi|387422 | Mdh2 | 8 | malate dehydrogenase | 1.37 | 0.0079 | 222 | 12 | 4 | 35588 | 8.93 | Metabolic pathways; Citrate cycle (TCA cycle); Pyruvate metabolism; |
gi|14198249 | Aldoc | 4 | Fructose-bisphosphate aldolase C | 1.34 | 0.0097 | 144 | 9 | 3 | 39307 | 6.47 | Metabolic pathways; Glycolysis/Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism |
gi|13097102 | Ddah2 | 2 | dimethylarginine dimethylaminohydrolase 2 | 1.32 | 0.0098 | 183 | 18 | 4 | 29627 | 5.66 | Â |
gi|33859640 | Taldo1 | 3 | transaldolase 1 | 1.34 | 0.0109 | 163 | 12 | 4 | 37363 | 6.57 | Metabolic pathways; Pentose phosphate pathway; |
gi|6681195 | Dlg4 | 4 | postsynaptic density protein 95 | 0.64 | 0.0133 | 38 | 4 | 2 | 80423 | 5.56 | Huntington's disease |
gi|6753476 | Cnp | 1 | cyclic nucleotide phosphodiesterase 1 | 1.42 | 0.0142 | 371 | 21 | 8 | 47094 | 9.08 | Â |
gi|27370516 | Idh2 | 6 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 1.37 | 0.0151 | 221 | 10 | 4 | 50902 | 8.88 | Metabolic pathways; Citrate cycle (TCA cycle); Glutathione metabolism; |
gi|54855 | Tpi1 | 25 | triosephosphate isomerase | 1.36 | 0.0214 | 770 | 42 | 12 | 26679 | 6.9 | Metabolic pathways; Glycolysis/Gluconeogenesis; Fructose and mannose metabolism; |
gi|12805413 | Echs1 | 2 | Echs1 protein | 1.31 | 0.0245 | 428 | 26 | 8 | 31237 | 8.76 | Metabolic pathways; Propanoate metabolism; |
gi|7305485 | Sh3gl1 | 4 | SH3-domain GRB2-like 1 | 1.28 | 0.0307 | 136 | 7 | 3 | 41492 | 5.53 | Endocytosis |
Midbrain: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
NCBI access number | Gene symbol | Number of isoforms | Protein name | Expression ratio (KO vs. wt) | T test (p-value) | Mowse score | Sequence coverage (%) | Number of matched peptides | Molecular weight (Da) | Theoretical pI | Functional annotation (KEGG pathway) |
gi|13384652 | Mecr | 1 | trans-2-enoyl-CoA reductase, mitochondrial precursor | 0.53 | 0.001 | 88 | 4 | 2 | 40316 | 9.34 | Metabolic pathways; |
gi|6679937 | Gapdh | 3 | similar to glyceraldehyde-3-phosphate dehydrogenase | 0.55 | 0.002 | 340 | 19 | 5 | 35787 | 8.44 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|12849397 | Glod4 | 1 | Glyoxalase domain-containing protein 4 | 0.69 | 0.003 | 545 | 46 | 11 | 33296 | 5.28 | Â |
gi|6753428 | Ckmt1 | 2 | creatine kinase, mitochondrial 1, ubiquitous | 0.77 | 0.003 | 123 | 14 | 2 | 46974 | 8.39 | Metabolic pathways; |
gi|18017596 | Snx4 | 1 | sorting nexin 4 | 0.39 | 0.007 | 140 | 6 | 2 | 51745 | 5.58 | Â |
gi|27369581 | Slc25a12 | 1 | solute carrier family 25 (mitochondrial carrier, Aralar), member 12 | 0.46 | 0.007 | 318 | 9 | 5 | 74523 | 8.43 | Â |
gi|21410877 | Rap1gap | 1 | Rap1gap protein | 0.72 | 0.007 | 62 | 9 | 2 | 45618 | 5.47 | Â |
gi|387129 | Mdh1 | 3 | cytosolic malate dehydrogenase | 0.74 | 0.01 | 145 | 11 | 3 | 36454 | 6.16 | Metabolic pathways; Citrate cycle (TCA cycle); Pyruvate metabolism; |
gi|33440467 | Pafah1b2 | 2 | Platelet-activating factor acetylhydrolase, isoform 1b, alpha2 subunit | 0.72 | 0.015 | 91 | 8 | 2 | 25476 | 5.57 | Metabolic pathways; |
gi|21759113 | Etfa | 2 | Electron transfer flavoprotein subunit alpha, mitochondrial precursor (Alpha-ETF) | 0.61 | 0.016 | 455 | 29 | 6 | 35018 | 8.42 | Â |
gi|1915915 | Ulip3 | 1 | Ulip3 protein | 0.73 | 0.016 | 177 | 12 | 3 | 62142 | 6.39 | Â |
gi|31981086 | Efhd2 | 3 | EF hand domain containing 2 | 0.66 | 0.018 | 602 | 45 | 9 | 25084 | 5.07 | Â |
gi|18606238 | Gsn | 1 | gelsolin | 0.7 | 0.018 | 328 | 9 | 5 | 80712 | 5.83 | Regulation of actin cytoskeleton |
gi|6671539 | Aldoa | 4 | aldolase 1, A isoform | 0.79 | 0.019 | 1158 | 59 | 17 | 39331 | 8.31 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|6678483 | Uba1 | 1 | ubiquitin-activating enzyme E1, Chr X | 0.76 | 0.021 | 669 | 13 | 10 | 117734 | 5.43 | Parkinson's disease |
gi|18152793 | Pdhb | 1 | pyruvate dehydrogenase (lipoamide) beta | 0.78 | 0.021 | 497 | 32 | 11 | 38912 | 6.41 | Metabolic pathways; Glycolysis/Gluconeogenesis; Citrate cycle (TCA cycle); Pyruvate metabolism; |
gi|6755963 | Vdac1 | 3 | voltage-dependent anion channel 1 | 0.66 | 0.0217 | 855 | 51 | 10 | 30737 | 8.62 | Parkinson's disease; Huntington's disease; Calcium signaling pathway |
gi|6755967 | Vdac3 | 1 | voltage-dependent anion channel 3 | 0.66 | 0.025 | 224 | 20 | 4 | 30733 | 8.96 | Parkinson's disease; Huntington's disease; Calcium signaling pathway |
gi|2690302 | Got2 | 2 | aspartate aminotransferase precursor | 0.77 | 0.027 | 533 | 23 | 8 | 47382 | 9.05 | Metabolic pathways; Alanine, aspartate and glutamate metabolism |
gi|11141704 | Sir2L2 | 1 | sirtuin 2 | 0.48 | 0.029 | 51 | 4 | 2 | 43244 | 8.22 | Â |
gi|22902419 | Gpd1l | 2 | glycerol-3-phosphate dehydrogenase 1-like | 0.48 | 0.029 | 61 | 4 | 2 | 42517 | 8.22 | Glycerophospholipid metabolism |
gi|7106301 | Mapre1 | 1 | microtubule-associated protein, RP/EB family, member 1 | 0.56 | 0.031 | 193 | 18 | 3 | 29997 | 5.12 | Â |
gi|8567410 | Syn2 | 1 | synapsin II | 0.61 | 0.034 | 70 | 3 | 2 | 52418 | 7.62 | Â |
gi|6671569 | Arbp | 2 | acidic ribosomal phosphoprotein P0 | 1.41 | 0.037 | 196 | 19 | 4 | 34195 | 5.91 | Â |
gi|9845299 | Suclg1 | 1 | succinate-CoA ligase, GDP-forming, alpha subunit | 1.21 | 0.039 | 88 | 9 | 2 | 34953 | 9.45 | Metabolic pathways; Citrate cycle (TCA cycle); Propanoate metabolism |
gi|61098212 | Uchl1 | 1 | ubiquitin carboxy-terminal hydrolase L1 | 0.65 | 0.04 | 157 | 16 | 3 | 24822 | 5.14 | Parkinson's disease |
gi|6754524 | Ldha | 6 | lactate dehydrogenase 1, A chain | 0.61 | 0.046 | 151 | 14 | 3 | 36475 | 7.62 | Metabolic pathways; Glycolysis/Gluconeogenesis; Pyruvate metabolism; Propanoate metabolism |
gi|29789104 | Napb | 1 | N-ethylmaleimide sensitive fusion protein attachment protein beta | 0.76 | 0.046 | 708 | 42 | 10 | 33536 | 6.41 | Â |
gi|7305027 | Eno2 | 4 | enolase 2, gamma neuronal | 0.69 | 0.047 | 861 | 43 | 13 | 47267 | 4.99 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|55931021 | Gdi2 | 3 | Gdi2 protein | 1.64 | 0.049 | 158 | 13 | 3 | 50506 | 5.93 | Â |
Cortex: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
NCBI access number | Gene symbol | Number of Isoforms | Protein name | Expression ratio (KO vs. wt) | T test (p-value) | Mowse score | Sequence coverage (%) | Number of matched peptides | Molecular weight (Da) | Theoretical pI | Functional annotation (KEGG pathway) |
gi|4760600 | Ak3 | 1 | adenylate kinase isozyme 3 | 0.66 | 0.0004 | 124 | 47 | 11 | 24625 | 8.57 | Â |
gi|13385942 | Cs | 5 | citrate synthase | 0.74 | 0.0057 | 130 | 28 | 16 | 51703 | 8.72 | Metabolic pathways; |
gi|37700232 | Nme1 | 4 | nucleoside-diphosphate kinase 1 | 1.22 | 0.0006 | 91 | 48 | 9 | 17197 | 6.84 | Metabolic pathways; |
gi|19547889 | Gss | 3 | glutathione synthetase | 1.24 | 0.0386 | 107 | 26 | 12 | 51913 | 6.52 | Metabolic pathways; |
gi|42542422 | Hspa8 | 5 | Heat shock protein 8 | 1.24 | 0.0019 | 180 | 35 | 23 | 68074 | 5.32 | Â |
gi|123230136 | Prdx1 | 1 | peroxiredoxin 1 | 1.24 | 0.0228 | 64 | 23 | 5 | 18915 | 6.82 | Â |
gi|37202121 | Abat | 3 | 4-aminobutyrate aminotransferase | 1.25 | 0.0005 | 227 | 37 | 24 | 56416 | 8.35 | Metabolic pathways; Alanine, aspartate and glutamate metabolism; Propanoate metabolism; Valine, leucine and isoleucine degradation |
gi|113680348 | Fscn1 | 2 | fascin homolog 1, actin bundling protein | 1.26 | 0.0017 | 168 | 42 | 17 | 54474 | 6.44 | Â |
gi|34784434 | Eno1 | 4 | Eno1 protein | 1.26 | 0.0062 | 139 | 43 | 16 | 39757 | 5.86 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|56789289 | Ldhb | 4 | Ldhb protein | 1.27 | 0.0011 | 86 | 42 | 7 | 11317 | 5.73 | Metabolic pathways; Glycolysis/Gluconeogenesis; Propanoate metabolism; Cysteine and methionine metabolism |
gi|6679439 | Ppia | 4 | peptidylprolyl isomerase A | 1.3 | 0.0006 | 99 | 53 | 12 | 17960 | 7.74 | Â |
gi|6755040 | Pfn1 | 3 | profilin 1 | 1.31 | 0.0022 | 176 | 73 | 14 | 14948 | 8.46 | Regulation of actin cytoskeleton |
gi|6678469 | Tuba1c | 2 | tubulin, alpha 1C | 1.32 | 0.0000088 | 98 | 35 | 13 | 49877 | 4.96 | Â |
gi|809561 | 3 | 1 | gamma-actin | 1.32 | 0.0028 | 230 | 56 | 24 | 41724 | 5.3 | Regulation of actin cytoskeleton |
gi|6679937 | Gapdh | 6 | glyceraldehyde-3-phosphate dehydrogenase | 1.33 | 0.0005 | 211 | 60 | 23 | 35787 | 8.44 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|49868 | Actb | 2 | beta-actin (aa 27-375) | 1.35 | 0.0019 | 237 | 54 | 27 | 39161 | 5.79 | Regulation of actin cytoskeleton |
gi|148686116 | Taldo1 | 2 | transaldolase 1, isoform CRA_e | 1.39 | 0.0008 | 156 | 51 | 18 | 31514 | 7.66 | Metabolic pathways; Pentose phosphate pathway |
gi|6678413 | Tpi1 | 1 | triosephosphate isomerase 1 | 1.39 | 0.0006 | 147 | 42 | 9 | 26696 | 6.9 | Metabolic pathways; Glycolysis/Gluconeogenesis; Fructose and mannose metabolism |
gi|123210063 | --- | 1 | novel protein | 1.44 | 0.0009 | 38 | 20 | 4 | 24445 | 8.76 | Â |
gi|6755963 | Vdac1 | 1 | voltage-dependent anion channel 1 | 1.47 | 0.0019 | 161 | 62 | 15 | 30737 | 8.62 | Â |
gi|6671539 | Aldoa | 4 | aldolase 1, A isoform | 1.52 | 0.005 | 179 | 43 | 17 | 39331 | 8.31 | Metabolic pathways; Glycolysis/Gluconeogenesis; Pentose phosphate pathway; Fructose and mannose metabolism |
gi|1915915 | Dpysl1 | 2 | Ulip3 protein | 1.56 | 0.0058 | 225 | 40 | 24 | 62142 | 6.39 | Â |
gi|20072952 | Auh | 2 | Auh protein | 1.62 | 0.000068 | 114 | 32 | 13 | 32621 | 9.57 | Metabolic pathways; Valine, leucine and isoleucine degradation |
gi|11066098 | Tkt | 1 | transketolase | 1.89 | 0.0058 | 65 | 26 | 11 | 60545 | 6.54 | Metabolic pathways; Pentose phosphate pathway; |
gi|21311871 | Nebl | 1 | nebulette | 2.2 | 0.0007 | 74 | 40 | 13 | 31093 | 8.54 | Â |
gi|163838648 | Atp5c1 | 1 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma subunit isoform b | 2.2 | 0.0007 | 126 | 42 | 15 | 30237 | 8.86 | Metabolic pathways; |
gi|202423 | Pgk1 | 2 (with divergent regulation) | phosphoglycerate kinase | 1.54; 0.77 | 5.00E-03; 1.22E-02 | 265 | 58 | 28 | 44522 | 8.02 | Metabolic pathways; Glycolysis/Gluconeogenesis; |
gi|160298209 | Got1 | 2 (with divergent regulation) | glutamate oxaloacetate transaminase 1, soluble | 1.62; 0.78 | 1.12E-02; 2.60E-03 | 130 | 30 | 12 | 46219 | 6.68 | Metabolic pathways; Alanine, aspartate and glutamate metabolism |